Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Decoy Therapeutics Inc (DCOY)

Decoy Therapeutics Inc (DCOY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,776
  • Shares Outstanding, K 6,384
  • Annual Sales, $ 0 K
  • Annual Income, $ -5,580 K
  • EBIT $ -5 M
  • EBITDA $ -5 M
  • 60-Month Beta 0.39
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.17
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -33.90
  • Most Recent Earnings $-1.81 on 11/14/25
  • Next Earnings Date 03/20/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -9.90
  • Growth Rate Est. (year over year) +10,190.91%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6150 +18.05%
on 02/05/26
1.4100 -48.51%
on 01/13/26
-0.0938 (-11.44%)
since 01/09/26
3-Month
0.5148 +41.03%
on 01/05/26
1.7300 -58.03%
on 11/12/25
-0.2540 (-25.92%)
since 11/11/25
52-Week
0.5148 +41.03%
on 01/05/26
34.6500 -97.90%
on 07/29/25
-26.4240 (-97.33%)
since 02/11/25

Most Recent Stories

More News
Decoy Therapeutics Joins Webull Corporate Connect Service Platform

-  Connect with the Company on Webull here

DCOY : 0.7260 (-2.95%)
JTC Team Companies to Present in Webull Corporate Connect Webinar Series Happening February 10-11, 2026

Register for the two-day virtual event here

AKTX : 0.2456 (+1.45%)
AIM : 0.8437 (-13.51%)
DCOY : 0.7260 (-2.95%)
BULL : 6.24 (-6.02%)
GRI : 2.39 (unch)
MBRX : 4.18 (+0.97%)
Decoy Therapeutics to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial

– Live video webcast on Tuesday, February 10 th at 1:20 PM EST

DCOY : 0.7260 (-2.95%)
Decoy Therapeutics Participates in Virtual Investor "What This Means" Segment Highlighting Recently Announced Global Access Commitment Agreement

Access the "What This Means" segment here

DCOY : 0.7260 (-2.95%)
Decoy Therapeutics Reaches Global Access Commitment Agreement to Focus on Development of a Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform

Decoy Therapeutics will use the platform, with funding support from the Gates Foundation, to provide widespread access to peptide-conjugate antivirals from Decoy's IMP 3 ACTâ„¢ platform...

DCOY : 0.7260 (-2.95%)

Business Summary

Decoy Therapeutics Inc. is a preclinical-stage biotechnology company which target serious unmet medical needs. The Company's initial pipeline is focused on respiratory viruses and GI cancers. Decoy Therapeutics Inc., formerly known as Salarius Pharmaceuticals Inc., is based in CAMBRIDGE, Mass.

See More

Key Turning Points

3rd Resistance Point 0.8807
2nd Resistance Point 0.8253
1st Resistance Point 0.7757
Last Price 0.7260
1st Support Level 0.6707
2nd Support Level 0.6153
3rd Support Level 0.5657

See More

52-Week High 34.6500
Fibonacci 61.8% 21.6104
Fibonacci 50% 17.5824
Fibonacci 38.2% 13.5544
Last Price 0.7260
52-Week Low 0.5148

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar